Vedbæk, Denmark

Marianne Dragheim

This inventor holds 3 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: H. Lundbeck A/s, Takeda Pharmaceuticals North America, Inc.. Active years: 2016-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marianne Dragheim. Retrieved from https://idiyas.com/inventor/marianne-dragheim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0


 

Average Co-Inventor Count = 1.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Vedbaek, DK (2016)
  • Vedbæk, DK (2017 - 2023)

Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marianne Dragheim

Introduction

Marianne Dragheim is a notable inventor based in Vedbæk, Denmark. She has made significant contributions to the field of pharmaceuticals, holding a total of three patents. Her work focuses on therapeutic uses of compounds that exhibit combined activity on various serotonin receptors.

Latest Patents

Among her latest patents is a groundbreaking invention related to the therapeutic uses of compounds having combined sert, 5-HT3, and 5-HT1a activity. Additionally, she has developed new pharmaceutical uses for 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine and its pharmaceutically acceptable salts. These innovations are poised to enhance treatment options in the pharmaceutical industry.

Career Highlights

Throughout her career, Marianne has worked with prominent companies such as H. Lundbeck A/S and Takeda Pharmaceuticals North America, Inc. Her experience in these organizations has allowed her to refine her expertise and contribute to significant advancements in drug development.

Collaborations

Marianne has collaborated with esteemed colleagues, including Nicholas Moore and Ioana Florea. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Marianne Dragheim's contributions to the pharmaceutical field through her patents and collaborations highlight her role as a key innovator. Her work continues to influence the development of new therapeutic options, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…